Style Guide

Main navigation

Click here for HCP site



Typography H1 or .text-h1

Typography H2 or .text-h2

Typography H3 or .text-h3

Typography H4 or .text-h4

Typography H5 or .text-h5
Typography H6 or .text-h6






Colour 0

Colour 1

Colour 2

Colour 3

Colour 4

Colour 5

Colour 6

Colour 7

Background colours


Background Clipping

.bg-pattern .bg-pattern-4

.bg-pattern .bg-pattern-3

.bg-pattern .bg-pattern-4 .bg-pattern--alt



.button .button--0

.button .button--1

.button .button--2

.button .button--3

.button .button--4

.button .button--5

.button .button--6

.button .button--7

.button .button--2 button--alt

.button .button--6 button--alt



Genetic confirmation of an LHON mutation means everyone on the maternal bloodline is at risk10


Sudden painless loss of central vision requires urgent diagnosis and treatment


Loss of vision in one eye followed by second eye?
History of blindness in the family?
Only central vision affected?
Now is the time to act.

If you see patients with any of the above, refer them to an ophthalmologist as soon as possible.


A lovely header

And a majestic body.

Lorem ipsum dolor sit amet consectetur adipisicing elit. Reiciendis voluptas dolores eum. Ab, deleniti saepe, ad qui veritatis ipsa vero accusantium, corporis unde officia ea dolorum distinctio maiores dolorem repellat!

A lovely header

This is a body for the card


Fundus examination during the acute phase and after
onset of vision loss11


Some lovely text


Some drugs are known to cause damage to the mitochondria. Due to this, it might be worth finding out more about these drugs and limiting their use.


CTA with clip & without the button


CTA, no clip one button


Disclaimer: The information on this website is intended only to provide knowledge of Leber’s hereditary optic neuropathy (LHON). This information should not be used in place of advice from your GP or a healthcare professional. If in doubt, please contact your doctor for advice. This website has been produced by Chiesi Pharmaceuticals. The website has been developed in accordance with industry and legal standards to provide information for healthcare professionals and the general public about LHON. Chiesi Pharmaceuticals makes every reasonable effort to include accurate and current information. However, the information provided in this website is not exhaustive.

In case you want to report an adverse drug reaction you have become aware of, please report it to your Health Authority according to the requirements set by the pharmacovigilance legislation.


Close references –


  • Desc